Presentation Double Antiplatelet Therapy After DES Implantation Presenter: I. Ferreira-Gonz?lez September 19, 2012
Presentation Cilostazol Added to Aspirin and Clopidogrel Reduces Revascularization Without Increases in Major Adverse Events in Patients With DES Presenter: Ryota Sakurai July 12, 2012
Presentation Prolonged Clopidogrel Use After BMS and DES Placement: The VA Drug-Eluting Stent Study Presenter: David P. Faxon June 08, 2012
Presentation Duration of DAPT and Long-term Clinical Outcome After Coronary DES Implantation Presenter: T. Tada June 01, 2012
News Daily News CREDO-Kyoto Published: Extended DAPT Appears to Raise Bleeding Without Curbing Ischemic Events L.A. McKeown June 01, 2012
Presentation ACC 2012 A New Strategy for Discontinuation of Dual Antiplatelet Therapy: Real Safety and Efficacy of 3-Month Dual Antiplatelet Therapy Following Zotarolimus-Eluting Stent Implantation: RESET Trial Presenter: Myeong-Ki Hong March 25, 2012
News Conference News ACC 2012 Three Months of Antiplatelet Therapy with Endeavor Equal to 1 Year with Other DES Jason Kahn March 24, 2012
Presentation ACC 2012 Adjunctive Cilostazol Versus Double Dose Clopidogrel After PCI with Drug Eluting Stent: The HOST-ASSURE Randomized Trial Presenter: Hyo-Soo Kim March 24, 2012
News Daily News Las Estatinas Reducen la Re-estenosis Tardía tras el Implante de un SLS Jason Kahn March 05, 2012
Presentation Impact of Statin Therapy on Late TLR After Sirolimus-Eluting Stent (SES) Implantation Presenter: 202206|M Natsuaki March 04, 2012
News Daily News HORIZONS-AMI: CKD Patients Fare Poorly Regardless of Stent Type, Antithrombotic Regimen Leah Lawrence September 29, 2011
News Conference News Landmark Analyses Show Downside of Prolonged Antiplatelet Therapy September 02, 2011
News Daily News Study Takes Clopidogrel into Account in Assessing DES Cost-Effectiveness Caitlin E. Cox June 24, 2011
News Daily News HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years Jason Kahn June 13, 2011
News Daily News GRAVITAS Published: No Benefit from High-Dose Clopidogrel in Poor Responders L.A. McKeown March 15, 2011